The narcoleptic borderland

Sleep Medicine

Volumn 4, Issue 1, 2003, Pages 3-4

  Siegel, Jerome M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTRANSMITTER; OREXIN;

CELL LOSS; CEREBROSPINAL FLUID ANALYSIS; DISEASE CLASSIFICATION; EDITORIAL; GENETIC MARKER; HLA SYSTEM; HUMAN; NARCOLEPSY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOMNOLENCE; SYMPTOMATOLOGY; WAKEFULNESS;

EID: 0037216845     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1389-9457(02)00192-2     Document Type: Editorial

References (13)

1. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469-474.
2. Nishino S, Ripley B, Overeem S, Lammers GJ, et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-41.
3. Peyron C, Faraco J, Rogers W, Ripley B, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-997.
4. John J, Wu MF, Siegel JM. Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs. Sleep Res Online 2000;3:23-28 http://www.sro.org/2000/John/23/.
5. Nishino S, Ripley B, Overeem S, Nevsimalova S, et al. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 2001;50:381-388.
6. Adam JA, Menheere, PP, van Dielen FM, Soeters PB, et al. Decreased plasma orexin-A levels in obese individuals. Int J Obes Relat Metab Disord 2002;26:274-276.
7. Higuchi S, Usui A, Murasaki M, Matsushita S, et al. Plasma orexin-A is lower in patients with narcolepsy. Neurosci Lett 2002;318:61-64.
8. Arihara Z, Takahashi K, Murakami O, Totsune K, et al. Immunoreactive orexin-A in human plasma. Peptides 2001;22:139-142.
9. Dalal MA, Schuld A, Haack M, Uhr M, et al. Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology 2001;56:1749-1751.
10. Kanbayashi T, Inoue Y, Chiba S, Aizawa R, et al. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res 2002;11:91-93.
11. Bassetti C, Gugger M, Bischof M, Mathis J, et al. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Sleep Med 2002;6.
12. Kiyashchenko LI, Mileykovskiy BY, Maidment N, Lam HA, et al. Release of hypocretin (orexin) during waking and sleep states. J Neurosci 2002;22:5282-5286.
13. Wu MF, John J, Maidment NT, Lam HA, Siegel JM. Hypocretin/orexin release in normal and narcoleptic dogs: effects of food deprivation, eating, sleep deprivation and movement. Am J Physiol Regu 2002;283:R1079-R1086.